rs35448940

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004656.4(BAP1):​c.1838C>T​(p.Thr613Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000705 in 1,614,082 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T613P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0035 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00041 ( 5 hom. )

Consequence

BAP1
NM_004656.4 missense

Scores

1
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15O:1

Conservation

PhyloP100: 2.24

Publications

11 publications found
Variant links:
Genes affected
BAP1 (HGNC:950): (BRCA1 associated protein 1) This gene belongs to the ubiquitin C-terminal hydrolase subfamily of deubiquitinating enzymes that are involved in the removal of ubiquitin from proteins. The encoded enzyme binds to the breast cancer type 1 susceptibility protein (BRCA1) via the RING finger domain of the latter and acts as a tumor suppressor. In addition, the enzyme may be involved in regulation of transcription, regulation of cell cycle and growth, response to DNA damage and chromatin dynamics. Germline mutations in this gene may be associated with tumor predisposition syndrome (TPDS), which involves increased risk of cancers including malignant mesothelioma, uveal melanoma and cutaneous melanoma. [provided by RefSeq, May 2013]
BAP1 Gene-Disease associations (from GenCC):
  • BAP1-related tumor predisposition syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • Kury-Isidor syndrome
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, G2P
  • renal cell carcinoma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0039590895).
BP6
Variant 3-52403190-G-A is Benign according to our data. Variant chr3-52403190-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 133665.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00354 (539/152268) while in subpopulation AFR AF = 0.0124 (516/41550). AF 95% confidence interval is 0.0115. There are 2 homozygotes in GnomAd4. There are 264 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 539 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004656.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BAP1
NM_004656.4
MANE Select
c.1838C>Tp.Thr613Met
missense
Exon 14 of 17NP_004647.1Q92560
BAP1
NM_001410772.1
c.1784C>Tp.Thr595Met
missense
Exon 14 of 17NP_001397701.1F8W6N3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BAP1
ENST00000460680.6
TSL:1 MANE Select
c.1838C>Tp.Thr613Met
missense
Exon 14 of 17ENSP00000417132.1Q92560
BAP1
ENST00000478368.1
TSL:1
c.341C>Tp.Thr114Met
missense
Exon 2 of 5ENSP00000420647.1H0Y8E8
BAP1
ENST00000469613.5
TSL:1
c.118-349C>T
intron
N/AENSP00000418320.1H7C4V7

Frequencies

GnomAD3 genomes
AF:
0.00350
AC:
533
AN:
152150
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0123
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.000923
AC:
232
AN:
251422
AF XY:
0.000699
show subpopulations
Gnomad AFR exome
AF:
0.0124
Gnomad AMR exome
AF:
0.000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000879
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.000410
AC:
599
AN:
1461814
Hom.:
5
Cov.:
32
AF XY:
0.000371
AC XY:
270
AN XY:
727206
show subpopulations
African (AFR)
AF:
0.0137
AC:
460
AN:
33480
American (AMR)
AF:
0.000738
AC:
33
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53342
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000198
AC:
22
AN:
1112012
Other (OTH)
AF:
0.00121
AC:
73
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
48
96
143
191
239
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00354
AC:
539
AN:
152268
Hom.:
2
Cov.:
33
AF XY:
0.00355
AC XY:
264
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.0124
AC:
516
AN:
41550
American (AMR)
AF:
0.000981
AC:
15
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68020
Other (OTH)
AF:
0.00142
AC:
3
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
25
51
76
102
127
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00220
Hom.:
0
Bravo
AF:
0.00419
ESP6500AA
AF:
0.00862
AC:
38
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00117
AC:
142
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
BAP1-related tumor predisposition syndrome (4)
-
-
4
not specified (5)
-
-
3
not provided (3)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
1
Melanoma, uveal, susceptibility to, 2 (1)
-
-
1
Melanoma, uveal, susceptibility to, 2;C3280492:BAP1-related tumor predisposition syndrome;C5676925:Kury-Isidor syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
17
DANN
Uncertain
0.97
DEOGEN2
Benign
0.021
T
Eigen
Benign
-0.87
Eigen_PC
Benign
-0.77
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.66
T
MetaRNN
Benign
0.0040
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.69
N
PhyloP100
2.2
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.34
N
REVEL
Benign
0.055
Sift
Benign
0.063
T
Sift4G
Benign
0.17
T
Polyphen
0.0010
B
Vest4
0.19
MVP
0.59
MPC
0.40
ClinPred
0.0017
T
GERP RS
3.6
PromoterAI
0.0076
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.014
gMVP
0.21
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35448940; hg19: chr3-52437206; COSMIC: COSV56232942; COSMIC: COSV56232942; API